| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 19 |
| 1 | POLYETHYLENE GLYCOL 3350 | 17 |
| 2 | METHOTREXATE | 14 |
| 3 | ARIPIPRAZOLE | 10 |
| 4 | CYTARABINE | 10 |
| 5 | QUETIAPINE | 9 |
| 6 | MERCAPTOPURINE | 8 |
| 7 | PEGASPARGASE | 8 |
| 8 | QUETIAPINE EXTENDED-RELEASE | 8 |
| 9 | CYCLOPHOSPHAMIDE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIBASIC CALCIUM PHOSPHATE,FERROSOFERRIC PHOSPHATE,DIBASIC POTASSIUM PHOSPHATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE AND MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | 1 | 0.0833 |
| 1 | THIOGUANINE | 6 | 0.0045 |
| 2 | MECASERMIN | 3 | 0.0044 |
| 3 | NITISINONE | 1 | 0.0015 |
| 4 | MIGLUSTAT | 1 | 0.0012 |
| 5 | BENZOCAINE | 1 | 0.0012 |
| 6 | PEGASPARGASE | 8 | 0.0011 |
| 7 | SODIUM FERRIC GLUCONATE COMPLEX | 1 | 0.0008 |
| 8 | ETHOSUXIMIDE | 1 | 0.0008 |
| 9 | MERCAPTOPURINE | 8 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 1 | Asparagine-specific Enzyme [EPC] | 8 | 0.0011 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0008 |
| 3 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0002 |
| 4 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 5 | Influenza A M2 Protein Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Osmotic Laxative [EPC] | 17 | 0.0001 |
| 7 | Cholinergic Muscarinic Antagonist [EPC] | 3 | 0.0001 |
| 8 | Glinide [EPC] | 1 | 0.0001 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |